Skip to content


Foscan (temoporfin) is a small molecule pharmaceutical. Temoporfin was first approved as Foscan on 2001-10-24. It has been approved in Europe to treat head and neck neoplasms and squamous cell carcinoma.
Trade Name Foscan
Common Name Temoporfin
Indication head and neck neoplasms, squamous cell carcinoma
Drug Class Benzoporphyrin derivatives
Get full access now